Evaxion Biotech A/S (NASDAQ:EVAX) Q1 2026 Earnings Call Transcript May 7, 2026
Evaxion Biotech A/S reports earnings inline with expectations. Reported EPS is $-0.01 EPS, expectations were $-0.01.
Operator: Good day, and thank you for standing by. Welcome to the Evaxion Business Update and First Quarter 2026 Financial Results Webcast and Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your...
